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Background
Most asthmatic patients respond favorably to corticoster-
oid therapy, however, a subpopulation of patients (5-10%)
display persistent immune activation and airway inflam-
mation, despite high doses of oral/inhaled corticosteroids.
The development of more predictive animal models that
incorporate the severe steroid-resistant phenotype are
needed to better define translational biomarkers and ther-
apeutic targets for this patient population.
Materials and methods
For the last 20 + years LRRI has been breeding and sensi-
tizing Beagle dogs such that they exhibit multiple allergic
phenotypes (asthma, dermatitis, and, rhinitis). Over those
years higher doses of steroids seem to be required to see a
similar effect. In three recent studies, dogs (n=6-8/study)
previously sensitized to ragweed (RW) allergen were
pretreated with vehicle or a) 1 week oral prednisolone
(15 mg/day), b) 2 weeks oral prednisolone (15mg/day), or c)
2 weeks inhaled fluticasone propionate (350 μg lung
deposited dose; BID). Blood leukocytes and lung inflam-
matory (bronchoalveolar lavage; BAL) cells were mea-
sured before during and after treatment-allergen challenge.
Changes in lung function (airway resistance and compli-
ance) were measured immediately after RW challenge and
at 24 hours post RW (MCh dose response for airways
hyperreactivity).
Results
One week of prednisolone treatment did not lead to any
significant attenuation of pulmonary function endpoints
or lung inflammation (except for a reduction in BAL
lymphocytes). Two weeks of prednisolone treatment led
to a significant reduction in BAL cells (neutrophils, eosi-
nophils, and lymphocytes) and in blood eosinophils,
however this did not correlate with any significant
change in airway function. Two weeks of inhaled flutica-
sone led to a significant reduction in BAL cells (neutrophils,
eosinophils, and lymphocytes) and in blood eosinophils,
however this did not correlate with any significant change
in airway function. Age of the dogs (e.g. number of allergen
challenges over the years) or their level of responsiveness to
allergen challenge did not seem to predict a better or worse
response to steroids.
Conclusions
Dogs sensitized to RW exhibit some features of a severe
steroid-resistant phenotype: high doses of oral or inhaled
steroid required to see an effect on inflammation, with no
significant effects on airway function. However, it raises
the question as to how one defines steroid resistance in
an animal model where the animals underlying allergic
disease is clinically stable unless purposely challenged with
allergen and then only receive steroid treatment as a
positive control during a treatment study.
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